| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/14/2004 | EP1437366A1 MHC antigen complexes for detecting and purifying antigen-specific T cells |
| 07/14/2004 | EP1436624A1 A method of diagnosis and treatment and agents useful for same |
| 07/14/2004 | EP1436418A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/14/2004 | EP1436404A2 Engineered templates and their use in single primer amplification |
| 07/14/2004 | EP1436400A1 Multi-cistronic vectors for gene transfer protocols |
| 07/14/2004 | EP1436394A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436331A1 Process for the production of egg yolk antibodies against organochlorine pesticides |
| 07/14/2004 | EP1436330A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436316A2 Subcellular targeting of therapeutic proteins |
| 07/14/2004 | EP1436233A2 Metal binding proteins and associated methods |
| 07/14/2004 | EP1436004A1 Crustaceans as production systems for therapeutic proteins |
| 07/14/2004 | EP1436002A1 Use of peptide vectors to improve the immune response to antigens |
| 07/14/2004 | EP1435996A2 Compositions comprising mixtures of therapeutic proteins and methods of producing the same |
| 07/14/2004 | EP1363935A4 Ter sites and ter binding proteins |
| 07/14/2004 | EP1248802B1 Soluble ctla4 mutant molecules and uses thereof |
| 07/14/2004 | EP0889907B1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH) |
| 07/14/2004 | EP0754227B1 Chimeric complement inhibitor proteins |
| 07/14/2004 | EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/14/2004 | EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression |
| 07/14/2004 | CN1513059A Enzymes having alpha amylase activity and method of use thereof |
| 07/14/2004 | CN1513000A Anti-osteopontin antibody and use thereof |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1511953A Construction of recombined human lymphotoxin alpha and producing process |
| 07/14/2004 | CN1511910A Method for preparing hydrolytic gelatin using combined enzyme |
| 07/14/2004 | CN1511847A Ubiquitin-like molecule coming from human dendritic cell and its codnig sequence and use |
| 07/14/2004 | CN1511841A Homoeotic box gene 9Brn-1 from quail and its use |
| 07/14/2004 | CN1157482C Compond with anti fungus activity and its preparing method |
| 07/14/2004 | CN1157478C Improved barster gene |
| 07/14/2004 | CN1157409C Genetically engineered fish growth hormone and its use in aquatic product culture |
| 07/14/2004 | CN1157406C Novel, ATP-sensitive potassium-channel proteins and genes for the same |
| 07/13/2004 | US6762348 Genetic control of plant growth and development |
| 07/13/2004 | US6762295 For the treatment or prevention of gastroduodenal disease associated heliobacter infections |
| 07/13/2004 | US6762291 Used to modify insects and worms, or cultured cells, resulting in p53 expression or mis-expression; modified organisms or cells are used in screening assays to identify potential pesticidal agents or therapeutics that interact with p53 |
| 07/13/2004 | US6762286 Modified vitamin K-dependent polypeptides |
| 07/13/2004 | US6762051 Methods of inhibiting helicobacter pylori |
| 07/13/2004 | US6762039 Identification of novel cysteine proteases in gram-positive microorganisms by providing the nucleic acid and amino acid sequences for the bacillus subtilis cysteine proteases cp1, cp2 and cp3 |
| 07/13/2004 | US6762038 Mammalian somatic cells having a homozygous disruption in the gene which encodes the endonbonuclease rnase l and a homyzgous disruption in the gene which encodes the double-stranded rna dependent kinase pkr are provided |
| 07/13/2004 | US6761893 Modified vaccinia ankara virus variant |
| 07/13/2004 | US6761889 Adjusting affinity of fab 27/26 fragments/polypeptides generating improved ragweed-induced histamine release inhibition; bronchodilator agents |
| 07/13/2004 | CA2131528C Methods and compositions for targeting the vasculature of solid tumors |
| 07/08/2004 | WO2004057002A2 Production of heterologous glycosylated proteins in bryophyte cells |
| 07/08/2004 | WO2004056987A1 Modulation of the thioredoxin pathway |
| 07/08/2004 | WO2004056872A1 Method of protecting thiol group of protein |
| 07/08/2004 | WO2004056850A2 Mutant proteins showing increased secretion |
| 07/08/2004 | WO2004056204A1 Polymer composition suitable for use in food products |
| 07/08/2004 | WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 07/08/2004 | WO2004024909A3 Recombinant colstridium neurotoxin fragments |
| 07/08/2004 | WO2004009759A9 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 07/08/2004 | WO2003096986A3 Compositions and methods for treatment of wounds |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003046204A8 Humanized collagen antibodies and related methods |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | WO2001022916A3 Novel hev antigenic peptide and methods |
| 07/08/2004 | US20040133356 Three-dimensional model of a Fc region of an IgE antibody and uses thereof |
| 07/08/2004 | US20040132976 Colon specific genes and proteins |
| 07/08/2004 | US20040132660 PRO256 polypeptide; wound healing and anticarcinogenic agents; cardiovascular disorders, atherosclerosis, and cardiac hypertrophy treatment |
| 07/08/2004 | US20040132646 Identification of a novel glutamine transporter |
| 07/08/2004 | US20040132192 Generating trangenic cells via insertion of vector coding preferential gene sequences; bioreactors |
| 07/08/2004 | US20040132181 Trans-splicing mediated photodynamic therapy |
| 07/08/2004 | US20040132180 Expression vector coding reporter protein for use as diagnostic tool in gene transformation analysis |
| 07/08/2004 | US20040132173 Optical microarray apparatus comprised of immobilized cells for concurrent monitoring of responses to test compounds; rational drug design and screening |
| 07/08/2004 | US20040132157 Novel protein and DNA thereof |
| 07/08/2004 | US20040132141 Using peripheral blood lymphocytes to generate immunoglobulins for treatment of cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 07/08/2004 | US20040132140 comprises using a cell resistant to a lectin which recognizes a sugar chain in which 1-position of fucose is bound to 6-position of N-acetylglucosamine in the reducing end through alpha -bond in a complex N-glycoside-linked sugar chain |
| 07/08/2004 | US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/08/2004 | US20040132137 Thyroid glycoprotein horomone for treatment and prevention of hyperthyroidism and graves' disease |
| 07/08/2004 | US20040132131 Methods for comparitive analysis of carbohydrate polymers and carbohydrate polymers identified using same |
| 07/08/2004 | US20040132112 Using transgenic cell coated microbead matrix for screening monoclonal antibodies and monoclonal antibody-producing cells; isolation of immunotherapeutic agents |
| 07/08/2004 | US20040132094 Combinatorial libraries of proteins having the scaffold structure of c-type lectinlike domains |
| 07/08/2004 | US20040132057 Tumor necrosis related receptor,TR7 |
| 07/08/2004 | US20040132053 Sphingosine kinase enzyme |
| 07/08/2004 | US20040132052 Comprises nucleotide sequences coding cell signaling glycoprotein for use in screening and identifying antagonist of cancer; tumor diagnosis and treatment; antitumor agents; drug screening |
| 07/08/2004 | US20040132028 Collection of repeat proteins comprising repeat modules |
| 07/08/2004 | US20040132022 Comprises nucleotide sequences coding growth factor for treatment and prevention of aberrations in cellular growth and differentiation; cancer diagnosis and treatment; antitumor agents |
| 07/08/2004 | US20040132021 Using presence of genetic variation in van buchem-sclerosteosis disease region to identify disorders resulting in either net excess bone formation or insufficient bone formation in humans; allelicvariation and bone disorders |
| 07/08/2004 | US20040132020 Novel enzyme gene and its expression product |
| 07/08/2004 | US20040132014 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 07/08/2004 | US20040132012 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 07/08/2004 | US20040131639 Novel recombinant tryptophan mutants of influenza |
| 07/08/2004 | US20040131634 Neisseria lactoferrin binding protein |
| 07/08/2004 | US20040131620 Human polyclonal antibody compositions |
| 07/08/2004 | US20040131609 Ultra high affinity neutralizing antibodies |
| 07/08/2004 | CA2549932A1 Production of heterologous glycosylated proteins in bryophyte cells |
| 07/08/2004 | CA2511228A1 Method of protecting thiol group of protein |
| 07/07/2004 | EP1434879A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 07/07/2004 | EP1434871A1 Selection of cells expressing heteromeric polypeptides |
| 07/07/2004 | EP1434866A2 Genes associated with mast cell activation |
| 07/07/2004 | EP1434865A2 Variants and exons of the glyt1 transporter |
| 07/07/2004 | EP1434860A2 Enzymes |
| 07/07/2004 | EP1434857A1 Method for production of recombinant proteins in eukaryote cells |
| 07/07/2004 | EP1434802A1 Human tissue factor antibodies |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434483A2 NUCLEIC ACIDS ENCODING LINKED CHROMO/FLUORESCENT DOMAINS AND METHODS FOR USING THE SAME |
| 07/07/2004 | EP1387884A4 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |